Advanced in Acute Pain

Dr. Alina C. Beaton

Internal Medicine
Roberto A Beaton M D Inc
4314 W Victory Blvd, 
Burbank, CA 
Advanced in Acute Pain
Roberto A Beaton M D Inc
4314 W Victory Blvd, 
Burbank, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alina Beaton is a primary care provider, practicing in Internal Medicine in Burbank, California. Dr. Beaton is rated as an Advanced provider by MediFind in the treatment of Acute Pain. Her top areas of expertise are Acute Pain and Abdominal Wall Surgery.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles and participated in 6 clinical trials in the study of Acute Pain.

Specialties
Internal Medicine
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

ROBERTO A BEATON M D INC
4314 W Victory Blvd, Burbank, CA 91505

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Prospective, Double-Blinded, Multi-Center Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
A Prospective, Double-Blinded, Multi-Center Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
Enrollment Status: Active_not_recruiting
Publish Date: August 20, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Two-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics and Preliminary Efficacy Study of CA-008 in Patients Undergoing Total Knee Arthroplasy
A Two-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics and Preliminary Efficacy Study of CA-008 in Patients Undergoing Total Knee Arthroplasy
Enrollment Status: Completed
Publish Date: May 08, 2024
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Open Ventral Hernia Repair, Abdominoplasty, Open Abdominal Hysterectomy, Laparoscopic-assisted Colectomy, and Reduction Mammoplasty
An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Open Ventral Hernia Repair, Abdominoplasty, Open Abdominal Hysterectomy, Laparoscopic-assisted Colectomy, and Reduction Mammoplasty
Enrollment Status: Completed
Publish Date: February 13, 2023
Intervention Type: Combination product
Study Drug: INL-001 implant
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen
A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen
Enrollment Status: Terminated
Publish Date: January 25, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Randomized, Active and Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis
A Phase 2, Randomized, Active and Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis
Enrollment Status: Unknown
Publish Date: January 17, 2023
Intervention Type: Drug
Study Drugs: Resiniferatoxin, Zilretta
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Efficacy, and Systemic Exposure of a Single Administration of FX301 Via Nerve Block for Management of Post-surgical Pain Following Bunionectomy
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Efficacy, and Systemic Exposure of a Single Administration of FX301 Via Nerve Block for Management of Post-surgical Pain Following Bunionectomy
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Drug
Study Drug: FX301
Study Phase: Phase 1
A Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic (in Popliteal Fossa) and Saphenous (in Adductor Canal) Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries
A Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic (in Popliteal Fossa) and Saphenous (in Adductor Canal) Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries
Enrollment Status: Completed
Publish Date: July 18, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo- and Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Combination of Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy
A Phase 2, Randomized, Double-Blind, Placebo- and Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Combination of Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Pregabalin and Acetaminophen (Ofirmev®) in Healthy Volunteers
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Pregabalin and Acetaminophen (Ofirmev®) in Healthy Volunteers
Enrollment Status: Completed
Publish Date: August 05, 2020
Intervention Type: Drug
Study Phase: Phase 1
Double-blinded, Placebo-controlled, Sequential Cohort, Multiple-Dose Escalation Study to Evaluate the Safety and Multiple Dose Pharmacokinetics of CT-044 HCl, a Reactive Species Decomposition Accelerant, in Healthy Human Volunteers
Double-blinded, Placebo-controlled, Sequential Cohort, Multiple-Dose Escalation Study to Evaluate the Safety and Multiple Dose Pharmacokinetics of CT-044 HCl, a Reactive Species Decomposition Accelerant, in Healthy Human Volunteers
Enrollment Status: Unknown
Publish Date: July 23, 2020
Intervention Type: Drug
Study Phase: Phase 1
Open-label, Crossover, Food Effect Study to Evaluate the Single Dose Pharmacokinetics of CT-044, a Reactive Species Decomposition Accelerant, in Healthy Human Volunteers
Open-label, Crossover, Food Effect Study to Evaluate the Single Dose Pharmacokinetics of CT-044, a Reactive Species Decomposition Accelerant, in Healthy Human Volunteers
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 10 Less Clinical Trials

3 Total Publications

Selective Inhibition of NaV1.8 with VX-548 for Acute Pain.
Selective Inhibition of NaV1.8 with VX-548 for Acute Pain.
Journal: The New England journal of medicine
Published: August 02, 2023
Similar Doctors
Advanced in Acute Pain
Dr. Kamran Kalpari
Internal Medicine
Advanced in Acute Pain
Dr. Kamran Kalpari
Internal Medicine
8797 Beverly Blvd, Suite 315, 
West Hollywood, CA 
 (7.6 miles away)
310-659-0123
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kamran Kalpari is a primary care provider, practicing in Internal Medicine in West Hollywood, California. Dr. Kalpari is rated as a Distinguished provider by MediFind in the treatment of Acute Pain. His top areas of expertise are Long Haul COVID, Glossitis, Pernicious Anemia, Laminectomy, and Endoscopy.

Advanced in Acute Pain
Dr. Karl A. Lorenz
Internal Medicine
Advanced in Acute Pain
Dr. Karl A. Lorenz
Internal Medicine
11301 Wilshire Blvd # 111-g, 
Los Angeles, CA 
 (10.6 miles away)
310-478-3711
Languages Spoken:
English

Karl Lorenz is a primary care provider, practicing in Internal Medicine in Los Angeles, California. Dr. Lorenz is rated as an Advanced provider by MediFind in the treatment of Acute Pain. His top areas of expertise are Chronic Pain, Acute Pain, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Experienced in Acute Pain
Dr. Yang Bai
Internal Medicine
Experienced in Acute Pain
Dr. Yang Bai
Internal Medicine

Woodland Hills Medical Center

20940 Burbank Boulevard, 
Woodland Hills, CA 
 (14.7 miles away)
833-574-2273
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Yang Bai is a primary care provider, practicing in Internal Medicine in Woodland Hills, California. Dr. Bai is rated as a Distinguished provider by MediFind in the treatment of Acute Pain. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Cardiomyopathy, Endoscopy, and Colonoscopy. Dr. Bai is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Beaton's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile